comprehensive -WSS

comprehensive

author：hotspot 2025-10-02 20:53:16 - browse：628

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Medicare drug price negotiation’s day in court

leisure time

WSS

Teachers share how revamped forgiveness program helped with their student loans

Even great ERs can’t make up for American health disparities

Cognito secures funding to test medical device for Alzheimer's

Create a giant ice tray with this foil pan hack to keep food cold this summer

Home health providers sue Medicare over payment cuts

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

explore

comprehensive

hotspot

Cancer drug shortages should be causing more outrage

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

State Dept. review finds Biden bears some blame for Afghanistan failures

White House announces new plan to address the growing threat of xylazine in overdose crisis

Jerome Adams on the need for new antivirals for Covid

General Catalyst, Summa Health deal will turn on physician buy

Drug repurposing or repositioning? The language matters

Parents surprise family after baby discharged from NICU after 170 days

How one medical school became remarkably diverse

Do digital therapeutics have a future in medicine?

focus

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

New Ultima Genomics DNA sequencer can read genome for $100

Congressmen charge Covid hearing ‘could have been an email’

Even great ERs can’t make up for American health disparities

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

entertainment

hotspot

leisure time

focus